Johnson Geoffrey B, Brunn Gregory J, Platt Jeffrey L
Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Crit Rev Immunol. 2003;23(1-2):15-44. doi: 10.1615/critrevimmunol.v23.i12.20.
Toll-like receptors activate innate and adaptive immune systems in mammals. This ancient family of receptors has been evolving since before the taxonomic split between the plant and animal kingdoms. The discovery of the mammalian Toll-like receptors was heralded as confirmation of a predicted biological system explicitly designed to detect exogenous molecules from micro-organisms. However, there is accumulating evidence that Toll-like receptors also detect endogenous agonists, such as the degradation products of macromolecules, products of proteolytic cascades, intracellular components of ruptured cells, and products of genes that are activated by inflammation. Here we review endogenous models of Toll-like receptor activation, a subject of extensive debate. Endogenous activation of mammalian Toll-like receptors may provide key insights for the treatment of multiple conditions, from atherosclerosis to transplant rejection.
Toll样受体激活哺乳动物的先天性和适应性免疫系统。这个古老的受体家族自植物和动物王国在分类学上分化之前就一直在进化。哺乳动物Toll样受体的发现被视为一个明确设计用于检测微生物外源分子的预测生物系统得到了证实。然而,越来越多的证据表明,Toll样受体也能检测内源性激动剂,如大分子的降解产物、蛋白水解级联反应的产物、破裂细胞的细胞内成分以及由炎症激活的基因的产物。在此,我们综述Toll样受体激活的内源性模型,这是一个备受广泛争议的主题。哺乳动物Toll样受体的内源性激活可能为从动脉粥样硬化到移植排斥等多种病症的治疗提供关键见解。